Search for Clinical Trial Results
Azotemia - 25 Studies Found
Status | Study |
Completed |
Study Name: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS Condition: Atypical Hemolytic Uremic Syndrome Date: 2009-02-12 Interventions: Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome Date: 2009-02-03 Interventions: Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease Condition: Atypical Hemolytic Uraemic Syndrome. Date: 2009-06-29 |
Completed |
Study Name: Rituximab in Patients With Relapsed or Refractory TTP-HUS Condition:
Date: 2007-09-17 Interventions: Drug: Rituximab Rituximab will be administered on weeks 1, 2, 3, and 4 at a dose of 375 mg/m2 per infusi |
Enrolling by invitation |
Study Name: The Role of Microparticles as a Biomarker Condition:
|